Yearly Archives: 2019


Stem Cell Clinic > 2019

Michael Schumacher update: How is Michael Schumacher doing – six years on? – Express.co.uk

By Stem Cell Treatment

Speaking to Shes Mercedes magazine last month, she said: He is in the best of hands right now and we are doing everything we can to help him.

Try to understand that we follow Michaels desire to keep his health a secret.

You can be sure that he is in the very best of hands and that we are doing everything humanly possible to help him.

Please understand if we are following Michaels wishes and keeping such a sensitive subject as health, as it has always been, in privacy.

Michael Schumachers fans have honoured Corinnas request, as Reiner Ferling, chairman of the Kerpen fan club, said they would provide all kinds of support.

He said: Unfortunately, the time has come again, the sixth anniversary of Michaels accident is coming around.

Six years full of hope that Michael will one day go out in public again. We know that Michael is in good hands, that he gets love, security and confidence.

Michael can count himself lucky to have such a strong family behind him.

Visit link:
Michael Schumacher update: How is Michael Schumacher doing - six years on? - Express.co.uk

Brain tumor organoids may be key to time-sensitive treatments for glioblastomas – Science Codex

By Stem Cell Treatment

PHILADELPHIA --Lab-grown brain organoids developed from a patient's own glioblastoma, the most aggressive and common form of brain cancer, may hold the answers on how to best treat it. A new study in Cell from researchers at Penn Medicine showed how glioblastoma organoids could serve as effective models to rapidly test personalized treatment strategies.

Glioblastoma multiforme (GBM) remains the most difficult of all brain cancers to study and treat, largely because of tumor heterogeneity. Treatment approaches, like surgery, radiation and chemotherapy, along with newer personalized cellular therapies, have proven to slow tumor growth and keep patients disease-free for some periods of time; however, a cure remains elusive.

"While we've made important strides in glioblastoma research, preclinical and clinical challenges persist, keeping us from getting closer to more effective treatments," said senior author Hongjun Song, PhD, Perelman Professor of Neuroscience in the Perelman School of Medicine at the University of Pennsylvania. "One hurdle is the ability to recapitulate the tumor to not only better understand its complex characteristics, but also to determine what therapies post-surgery can fight it in a timelier manner."

Co-senior authors include Guo-li Ming, MD, PhD, Perelman Professor of Neuroscience, and Donald O'Rourke, MD, the John Templeton, Jr., MD Professor in Neurosurgery, and director of the GBM Translational Center of Excellence at Penn's Abramson Cancer Center.

Lab-grown brain organoids -- derived from human pluripotent stem cells or patient tissues and grown to a size no bigger than a pea -- can recapitulate important genetic composition, brain cell type heterogeneity, and architecture, for example. These models are allowing researchers to recreate key features of patients' diseased brains to help paint a clearer picture of their cancer, and allowing them to explore ways to best attack it.

What makes organoids so attractive in GBM is timing and the ability to maintain cell type and genetic heterogeneity. While existing in vitro models have added to researchers' understanding of the biological mechanisms underlying the cancer, they have limitations. Unlike other models, which need more time to exhibit gene expression and other histological features that more closely represent the tumor, brain tumor organoids developed by the research group grow into use much more rapidly. That's important because current treatment regimens are typically initiated one month following surgery, so having a road map sooner is more advantageous.

In the new study, the researchers removed fresh tumor specimens from 52 patients to "grow" corresponding tumor organoids in the lab. The overall success rate for generating glioblastoma organoids (GBOs) was 91.4 percent, with 66.7 percent of tumors expressing the IDH1 mutation, and 75 percent for recurrent tumors, within two weeks. These tumor glioblastoma organoids can also be biobanked and recovered later for analyses.

Genetic, histological, molecular analyses were also performed in 12 patients to establish that these new GBOs had largely retained features from the primary tumor in the patient.

Eight GBO samples were then successfully transplanted into adult mouse brains, which displayed rapid and aggressive infiltration of cancer cells and maintained key mutation expression up to three months later. Importantly, a major hallmark of GBM -- the infiltration of tumor cells into the surrounding brain tissue -- was observed in the mouse models.

To mimic post-surgery treatments, the researchers subjected GBOs to standard-of-care and targeted therapies, including drugs from clinical trials and chimeric antigen receptor T (CAR-T) cell immunotherapy. For each treatment, researchers showed that the organoid responses are different and effectiveness is correlated to their genetic mutations in patient tumors. This model opens the possibility for future clinical trials for personized treatment based on individual patient tumor responses to various different drugs.

Notably, the researchers observed a benefit in the organoids treated with CAR T therapies, which have been used in ongoing clinical trials to target the EGFRvIII mutation, a driver of the disease. In six GBOs, the researchers showed specific effect to patient GBOs with the EGFRvIII mutation with an expansion of CAR T cells and reduction in EGFRvIII expressing cells.

"These results highlight the potential for testing and treating glioblastomas with a personalized approach. The ultimate goal is to work towards a future where we can study a patient's organoid and test which CAR T cell is going to be the best against their tumor, in real time." O'Rourke said. "A shorter-term goal, given the heterogeneity of glioblastomas, is that in vitro testing of various therapeutic options may also help refine patient enrollment in clinical trials, by more accurately defining mutations and selecting the appropriate, available targeted therapies for each."

Here is the original post:
Brain tumor organoids may be key to time-sensitive treatments for glioblastomas - Science Codex

Health care in America is dysfunctional but its lack of transparency is downright dangerous – NBC News

By Stem Cell Treatment

Wow, you survived cancer? What's your secret to health care?

As absurd as that sounds, its a question many Americans who get sick are still asking as we ring in the year 2020. Getting health care in this country is still so circuitous it often does feel like a secret a maze deciphered in private that's never quite mastered. The reward for solving it? Perhaps your life; perhaps the loss of your life savings. And thats if youre lucky.

Even with the Affordable Care Act, almost 30 million are without health insurance in the U.S. And if youve perused plans on the ACA marketplace, youll know why. Theyre pricey, and a new year brings fears that insurance premiums are once again rising. (Who knew the inflation rates on a pap smear were that high?!) Meanwhile, 14 Republican-led states are still refusing to expand Medicaid as stipulated in the ACA, even though the federal government would pay for 90 percent of the cost. Why? Something about repeal and replace or socialism. Its hard to keep track.

Even with the Affordable Care Act, almost 30 million are without health insurance in the U.S. And if youve perused plans on the ACA marketplace, youll know why.

I traveled to three states, each with their own unique health care access challenges, for my new MSNBC special "Red, White, and Who? Between Texas, New York and Utah there are major differences in how easy it is to see a doctor without going bankrupt. But every single person I spoke with regardless of job, socioeconomic status or even political affiliation had one identical anxiety: healthcare in one of the most advanced countries in the world is ridiculously, hopelessly complicated.

Get the think newsletter.

Im retired, but I feel like a have a job, Larry Chiuppi told me sitting outside at an RV park in Houston, blocks from one of the top cancer treatment hospitals in the country. Larry has been caring for his wife Nancy Raimondi, who has blood cancer, for over a year. During that time, he himself was diagnosed with prostate cancer. Even with her Medicare and his private health plan under the ACA, navigating the billing systems for the endless hospital visits, specialists and tests each with their own separate charges requires a huge amount of time and vigilance. He tells me they once got a $14,000 bill for a stem cell transplant because someone forgot to link Nancys Medicare. Larry imagined many people wouldve just tried to pay it. And most Americans dont have a retirees free time and Larrys persistence to help them through the bureaucracy, an added burden of getting well.

We also dont all have a mother like Sandra Stein. She and her family live in New York, a state where the uninsured population is less than five percent, and 6.5 million are on Medicaid. I met Sandra on a street corner in upper Manhattan, where activists were flyering for the New York Health Act, a bill that would give every New Yorker state-funded care. Sandra believes in single-payer healthcare because she has experienced the mind-numbing labyrinth that is the private insurance system firsthand.

When her son was nearly three, he developed a rare neurological disease that left him unable to walk or speak. At the time, she and her husband had private insurance, which was relatively good insurance, according to Sandra. But that didnt make things easier. When they first went to the hospital in an ambulance, the doctors there didnt take their insurance even though the hospital did. Her son ultimately stayed in three different hospitals over the course of 15 months.

When we got home it was my job to figure out the pile of bills and the collections threats, she told me. Its been eight years, but Sandras voice cracked like the memory happened yesterday. I couldnt imagine how hard it mustve been to be afraid for your childs life while collections agents breathed down your neck. Sandra says the billing department sought her out even while her son was in the ICU, and that there were so many billing errors that she ultimately asked for an audit.

And yet, Sandra, Larry and Nancy are the lucky ones. They have health insurance, and they have the time and resources to be able to make their way through the bureaucratic hall of mirrors and toward a fighting chance at getting well.

Its this cruel opacity of the private insurance system, on top of the rising monthly costs of just having a plan, that can be the difference between life and death. And it keeps a surprising number of Americans away from the system altogether. Like a rodeo cowboy I met in Texas, whose story youll just have to watch (Im not spoiling it all!). Its also led Americans like Sandra to believe that a massive simplification of our health care system is far overdue.

For many, that simplification comes in the form of cutting out the profit motive and moving toward government-funded insurance, like Medicare for All, which Big Pharmas enemy number one Sen. Bernie Sanders and I hashed out over bagels in a New York City deli.

Ultimately what became clear through my travels is that healthcare in America is often overpriced and even dysfunctional, but its the lack of transparency that can be the most insidious. You pretty much have to be a health care policy expert, or have a loved one who can quit their job to become one, in order to ensure proper help.

Its also strange that in a country that loves the free market as much as we do, we the consumer have no idea how much anything costs when we walk into a hospital. Why would we? Our health is priceless, so we are simply at the mercy of an ineffective system. That is, unless we fight for something different.

Red, White, and Who premieres on MSNBC on Dec. 29 at 9 p.m. E.T.

Francesca Fiorentini is journalist and comedian. She is the host of "Red, White and Who?" on MSNBC and Newsbroke on AJ+. Follow her @franifio.

See the article here:
Health care in America is dysfunctional but its lack of transparency is downright dangerous - NBC News

Animal Stem Cell Therapy Market Research Report 2026 Observational Studies With Top Manufacturers – Market Research Sheets

By Stell Cell Research

The Animal Stem Cell Therapy Market is expected to increase more and rapidly, claims the latest report added by SMI.

Animal Stem Cell Therapy Market Outlook from 2019 to 2026. The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Animal Stem Cell Therapy market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Animal Stem Cell Therapy market. The report offers an overview of the market, which briefly describes the market condition and the leading segments. It also mentions the top players present in the global Animal Stem Cell Therapy market.

Click to Download Free Global Animal Stem Cell Therapy Market Research Sample PDF Copy Here: https://www.stratagemmarketinsights.com/sample/15082

This comprehensive Animal Stem Cell Therapy research report encompasses a brief on these trends, size, share that can assist the institutions, organizations, corporations, and individuals functioning in the industry to know the Animal Stem Cell Therapy market and strategize for their business growth accordingly. The research report breakdowns the market size, industry share, growth, key segments, CAGR, Application, Type, Application and key drivers.

To comprehend Global Animal Stem Cell Therapy market dynamics in the world mainly, the worldwide Animal Stem Cell Therapy market is analyzed across major global regions. Stratagem Market Insights also provides customized specific regional and country-level reports for the following areas.

North America(United States, Canada & Mexico)Asia-Pacific(Japan, China, India, Australia, etc)Europe(Germany, UK, France, etc)Central & South America(Brazil, Argentina, etc)Middle East & Africa(United Arab Emirates, Saudi Arabia, South Africa, etc)

Geographical Analysis

In order to get a deeper view of Market Size, competitive landscape is provided i.e. Revenue (Million USD) by Players (2014-2019), Revenue Market Share (%) by Players (2014-2019) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.

Key highlights from the Study:

1) Any Value Addition Chapters to Provide out of box Assessment?

Market Concentration: Includes C4 Index, HHI, Comparative Market Share Analysis (Y-o-Y), Major Companies, Emerging Players with Heat Map Analysis

Market Entropy: It will provide the randomness of the market which will help you understand the markets aggressiveness; players constantly do expansions, technological advancement, M&A, joint ventures.

Patent Analysis: To overcome competition, players constantly make R&D expenses and to better evaluate uncertain growth scenarios of market players and overall industry a patent analysis chapter introduces which will provide insights like no. of patents issued by players each year.

Peer Analysis: An evaluation of peer to peer analysis by key financial metrics such as EBITDA Margin, Net Profit Margin, Gross Margin, Total Revenue, Segmented Market Share, Assets, etc.

Grab Exclusive Discount on Animal Stem Cell Therapy Market Research @ https://www.stratagemmarketinsights.com/discount/15082

2) How Companies are profiled in the report?

A detailed assessment is done on the list of companies taken into consideration by following certain industry standards to reach the most relevant profile or manufacturers. More emphasis is given on SMEs that are emerging and evolving in the market with their product presence and technological upgraded modes, players that are also part of the study taken from a vast list.

** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.

3) Can we add or profiled a new company or customize the list of companies in the final study?

Yes, we can add or profile a new company as per client needs in the final report. Final confirmation will be provided by the research team depending upon the difficulty of the survey.

** Data availability will be confirmed by research in the case of a privately held company. Few players can be added at no added cost.

4) What details will the competitive landscape will provide?

A value proposition chapter to help you understand what level of business strategies key players are involved along with investment and deal size to gauge market. 2-Page profiles for all listed manufacturers along with 3 years of financial data to evaluate their overall performance in the market along with business overview, product specification, headquarter details, etc.

5) What all regional segmentation covered? Can a specific country of interest be added?

Currently, the research report gives special attention and focus on the following regions:

Asia-Pacific, North America, Europe, South America & Middle East & Africa

** Countries of specific interest can be included.

6) Can the inclusion of additional Segmentation / Market breakdown is possible?

Yes, the inclusion of additional segmentation / Market breakdown is possible subject to data availability and difficulty of survey. However, a detailed requirement needs to be shared with our research before giving final confirmation to the client.

** Depending upon the requirement the deliverable time may vary.

Contact us if any queries before the purchase on this report @ https://www.stratagemmarketinsights.com/quiry/15082

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.

For More Related Reports: CLICK HERE

This post was originally published on Market Research Sheets

Visit link:
Animal Stem Cell Therapy Market Research Report 2026 Observational Studies With Top Manufacturers - Market Research Sheets

Stem Cell Alopecia Treatment Market Segmentation, Top Companies, Applications, Comprehensive Research Report and Forecast to 2026 – Market Research…

By Stell Cell Research

The recent report added by Verified Market Research gives a detailed account of the drivers and restraints in the Global Stem Cell Alopecia Treatment market. The research report, titled [Global Stem Cell Alopecia Treatment Market Size and Forecast to 2026] presents a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Stem Cell Alopecia Treatment market and the current trends that are likely to shape its future. Primary and secondary research methodologies have been used to put together an exhaustive report on the subject. Analysts have offered unbiased outlook on the global Stem Cell Alopecia Treatment market to guide clients toward a well-informed business decision.

The comprehensive research report has used Porters five forces analysis and SWOT analysis to give the readers a fair idea of the direction the global Stem Cell Alopecia Treatment market is expected to take. The Porters five forces analysis highlights the intensity of the competitive rivalry while the SWOT analysis focuses on explaining strengths, weaknesses, opportunities, and threats present in the global Stem Cell Alopecia Treatment market. The research report gives an in-depth explanation of the trends and consumer behavior pattern that are likely to govern the evolution of the global Stem Cell Alopecia Treatment market.

The following Companies as the Key Players in the Global Stem Cell Alopecia Treatment Market Research Report:

Regions Covered in the Global Stem Cell Alopecia Treatment Market:

Europe (Germany, Russia, UK, Italy, Turkey, France, etc.)

The Middle East and Africa (GCC Countries and Egypt)

North America (United States, Mexico, and Canada)

South America (Brazil etc.)

Asia-Pacific (China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

The scope of the Report:

The research report on global Stem Cell Alopecia Treatment market includes segmentation on the basis of technology, application, end users, and region. Each segmentation is a chapter, which explains relevant components. The chapters include graphs to explain the year-on-year progress and the segment-specific drivers and restraints. In addition, the report also provides the government outlooks within the regional markets that are impacting the global Stem Cell Alopecia Treatment market.

Lastly, Verified Market Researchs report on Stem Cell Alopecia Treatment market includes a detailed chapter on the company profiles. This chapter studies the key players in the global Stem Cell Alopecia Treatment market. It mentions the key products and services of the companies along with an explanation of the strategic initiatives. An overall analysis of the strategic initiatives of the companies indicates the trends they are likely to follow, their research and development statuses, and their financial outlooks. The report intends to give the readers a comprehensive point of view about the direction the global Stem Cell Alopecia Treatment market is expected to take.

Ask for Discount @https://www.verifiedmarketresearch.com/ask-for-discount/?rid=15102&utm_source=MRS&utm_medium=002

Table of Content

1 Introduction of Stem Cell Alopecia Treatment Market

1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources

4 Stem Cell Alopecia Treatment Market Outlook

4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis

5 Stem Cell Alopecia Treatment Market, By Deployment Model

5.1 Overview

6 Stem Cell Alopecia Treatment Market, By Solution

6.1 Overview

7 Stem Cell Alopecia Treatment Market, By Vertical

7.1 Overview

8 Stem Cell Alopecia Treatment Market, By Geography

8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Rest of the World 8.5.1 Latin America 8.5.2 Middle East

9 Stem Cell Alopecia Treatment Market Competitive Landscape

9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments

11 Appendix

11.1 Related Research

Request Customization of Report @ https://www.verifiedmarketresearch.com/product/stem-cell-alopecia-treatment-market/?utm_source=MRS&utm_medium=002

We also offer customization on reports based on specific client requirement:

1- Free country level analysis for any 5 countries of your choice.

2- Free Competitive analysis of any market players.

3- Free 40 analyst hours to cover any other data points

About Us:

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research reports.

Contact Us:

Mr. Edwyne Fernandes Call: +1 (650) 781 4080 Email: [emailprotected]

This post was originally published on Market Research Sheets

Read the original:
Stem Cell Alopecia Treatment Market Segmentation, Top Companies, Applications, Comprehensive Research Report and Forecast to 2026 - Market Research...

Stem Cell Cartilage Regeneration Market Key players, Geographical Regions and Growth Analysis Outlook Up To 2028 – Sound On Sound Fest

By Stell Cell Research

New York City, NY: December 2019 Published via (Wired Release) If you are involved in the Stem Cell Cartilage Regeneration industry or intend to be, then this examine will offer you a comprehensive outlook. Its vital statistics to preserve your market expertise as much as date.

The global Stem Cell Cartilage Regeneration Market Research Report 2019-2028 accommodates a treasured bunch of data that light up the most critical sectors of the Stem Cell Cartilage Regeneration market. The statistics available in the file delivers all-inclusive facts approximately the Stem Cell Cartilage Regeneration marketplace, which is understandable for an expert. The global Stem Cell Cartilage Regeneration marketplace file provides data concerning all of the aspects associated with the marketplace, which incorporates opinions of the very last product, and the key factors hampering the market growth. It suggests how distinctive gamers are competing within the global Stem Cell Cartilage Regeneration market and discusses strategies theyre using to distinguish themselves from other participants.

To Comprehend The Complete Report Through TOC, Figures, and Tables, Get Free Sample Copy (Download PDF) @https://marketresearch.biz/report/stem-cell-cartilage-regeneration-market/request-sample

The geographical division offers statistics that offer you a concept of the revenue of the groups and sales figures of the Stem Cell Cartilage Regeneration For boom business. Here are highlights of the Geographical Divisions: Asia-Pacific (China, Japan, Korea, India, and Southeast Asia and more), North America (United States, Canada, and Mexico), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa), South America (Brazil, Argentina, Colombia), Europe (Germany, Spain, France, UK, Russia and Italy and more) and ROW (Rest-of-the-World).

Global Stem Cell Cartilage Regeneration Market 2019-2028 Competitive Landscape:-

A variety of leading gamers mention inside the Global Stem Cell Cartilage Regeneration Market research document are focusing on increasing operations in regions, as they exhibit ability business opportunities. The Global Stem Cell Cartilage Regeneration Market record classifies the marketplace dynamics and trends in the international and regional markets considering several aspects together with technology, supplies, capacity, production, profit, and price.

The document reviews the aggressive landscape scenario seen amongst top Stem Cell Cartilage Regeneration Sales players, their employer profile, revenue, sales, business tactics, and forecast Stem Cell Cartilage Regeneration Sales industry situations. According to the research, Stem Cell Cartilage Regeneration Sales marketplace is rather competing and disparate because of worldwide and neighborhood vendors. The global Stem Cell Cartilage Regeneration Sales marketplace record chiefly includes following players- Companies

Segmentation of Global Stem Cell Cartilage Regeneration Market:

Segmentation by stem cell type:

Hematopoietic Stem Cells (HSCs)Pluripotent Stem Cells (iPSC/ESCs)Mesenchymal Stem Cells (MSCs)Segmentation by treatment:

MicrofractureOsteochondral TransplantAutologous Chondrocyte ImplantationStem Cell InjectionsSegmentation by end user:

Hospitals & ClinicsAmbulatory Surgical Centers

Have Any Query? Ask Our Expert @https://marketresearch.biz/report/stem-cell-cartilage-regeneration-market/#inquiry

Global Stem Cell Cartilage Regeneration Market 2019-2028 : Research Methodology

A Detailed Study of Stem Cell Cartilage Regeneration Market includes the assessment of PORTERS Five Forces Analysis, PESTLE Analysis, Product Life Cycle Analysis, with Opportunity Maps. These analysis strategies can permit you to establish the highest competitive forces to form your business and to work out organization strategy. In this research study, we gathered, analyzed and interpreted records approximately Stem Cell Cartilage Regeneration market, approximately a product and its services, about the beyond and present commercial enterprise targets. This Market research includes two forms of data: Primary data which includes An institution survey and The in-depth interviews, Secondary Research Information assembled by means of media sources, exchange associations, government agencies, chambers of commerce, exertions unions, and so on. Secondary studies normally published in newsletters, pamphlets, magazines, alternate publications, and newspapers.

Highlights of Report:

1. Distribution Channel Assessment

2. Latest and Future Innovation Trends

3. Competitive Strategies

4. Niche Market Trends

5. Market Entry Analysis

6. Market Size and Forecasts

How is this Report On Stem Cell Cartilage Regeneration Market Useful?

In order to realize the understanding and insights acquired from this report, a few figures and presentations are also included other than the data. These are in the shape of charts, graphs, tables, etc. Rather than studying the raw data, studying through the equipment is less complicated and greater conclusions can be drawn looking at these explaining diagrams.

This report also offers hands-on ready-to-get right of entry to analytical facts furnished by enterprise professionals. They can recognize various essential trends, drivers, and demanding situations in the Stem Cell Cartilage Regeneration industry. This report will provide a detailed assessment of majorly the fundamental players, areas considered, and applications.

Contact Us:

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel: +1 347 826 1876

Website:https://marketresearch.biz

Email ID:inquiry@marketresearch.biz

See the original post:
Stem Cell Cartilage Regeneration Market Key players, Geographical Regions and Growth Analysis Outlook Up To 2028 - Sound On Sound Fest

Scientists race to use zero gravity to kill the worst cancers – Big Think

By Stell Cell Research

Can being in zero gravity help beat cancer? A growing field of research, including an upcoming research mission to the International Space Station, is hoping to prove just that.

Joshua Chou, a biomedical engineer from the University of Technology Sydney in Australia, has conducted successful trials in a lab environment, and aims to establish that zero-g can kill cancer cells.

Zero gravity or weightlessness occurs in the absence of the sensation of weight, when no contact forces act upon an object (or a body).

Chou's work looks to pinpoint the sensors by which cancer cells find each other and grow into tumors within a body. He thinks these receptors are dependent on gravity and once it's removed, the cancer can be stopped as the cells won't be able to "sense" each other.

To study this approach further, a graduate student working with Chou created the first microgravity device in Australia. The apparatus is a tissue box-sized spinning container. The researcher described it as "something that looks like the pods astronauts train in."

Joshua Chou with a prototype of Australia's first microgravity device.

Photo by Sissy Reyes.

The device has allowed Chou's team to investigate how microgravity affects different diseases. The scientists report it has been tremendously effective so far in eliminating cancer cells.

Normally, these are the hardest cancers to fight. Chou's experiments, without using any drugs, managed to either kill such cells or make them "float off because they can no longer hold on."

Early in 2020, Chou and his team will be able to test their approach in space, launching a specially-designed module with the help of SpaceX. The module will be loaded with the four types of cancer cells (ovarian, breast, nose and lung). Once launched, the scientists will be able to monitor it from Earth via data feeds. The experiment is set to last seven days, after which the cells will be frozen and send back to Earth 21 days later on a shuttle. More studies will be conducted once the cells are back in the lab on the ground.

The research team, from left, Chelsea Ly, Carin Basirun, Jessica Domingo and Joshua Chou.

Photo: Joshua Chou.

If Chou and his team succeed, does that mean cancer patients will be sent to space for treatment? While there may be such eventualities as well, Chou's vision is to develop a drug that patients can take while on Earth. He hopes to use it to "trick" cancer cells into behaving like they are in space.

Chou also thinks that this kind of therapy might not be a "magic bullet" that will work on its own, but rather in conjunction with existing treatments. "It could give current treatments like chemotherapy a big enough boost to kill the disease," he adds in a recent article.

Chou's research is not the only one of its kind. Nine research projects are going to study the effects of weightlessness on cancer aboard the new China Space Station (CSS), set for 2022. One such project is "Tumours in Space" that will look at how microgravity and cosmic radiation can affect the growth of tumors.

Tricia L. Larose from the Norwegian University of Science and Technology, who is the project's Principal Investigator, explained their goal:

Organoids are three-dimensional cancerous tumors that can form small structures mimicking different organs.

Scientists in other countries are also looking at utilizing gravity on cancer. In 2017, a German team, led by professor Daniela Grimm from the University of Magdeburg, studied the effects of space on thyroid cancer cells. This was, in fact, the third time Grimm's team sent such samples into space. Their objective, as Grimm expressed in an interview, is "to find growth-regulating proteins and certain receptors that express and secrete differently in space versus on Earth." If they can find such proteins and receptors, they can develop new drugs to treat the cancers back on our home planet.

The Influence of short-term #Microgravity on Human Prostate CancerThe Influence of short-term #Microgravity on Human Prostate Cancer Cells during a Parabolic Flight . By Prof. Daniela Grimm from University of Magdeburg . Dr...

Related Articles Around the Web

See the original post here:
Scientists race to use zero gravity to kill the worst cancers - Big Think

How technology has changed the world in the last decade – The Upcoming

By Stell Cell Research

How technology has changed the world in the last decade

Technology has changed the world in many ways during the last decade. Medicine- technology has enabled robots and remote location surgeries, it has reduced the chances of infection and disease, it has speeded up the process of delivering medicines and life-saving drugs.

Every day, technology is creating more breakthroughs to fight serious illnesses that have resulted in high mortality in the past. Stem cell research gives patients a new lease on life, as do artificial limbs.

Travelling

Gone are the days when we stood in line for tickets. No more talking on the phone with the travel agent for good deals. Now, travel is online and forever changed. You can go online to research your destination and find information you need. From where to stay to what to wear there, every piece of travel information can be found. Now, you can track a flight, train or car, you can use GPS to find a destination, you can book and cancel tickets online and plan your trip down to the exact minute.

Finance

When was the last time you went to a bank to pull out money or update your passbook? Hard to remember, isnt it? Technology has made the world of banking and finance accessible for everyone. You can do all your banking transactions online, keep an eye on your stock portfolio, and invest in funds of your liking.

Shopping and gaming

More and more people are choosing to shop online. Thanks to technology, huge retail chains have websites where you can buy anything from a pin to a plane. Customers are spoilt for choice, deals are almost irresistible, and delivery is hassle-free.

From fantasy league football to watching matches with high speed internet, the world of games and play has changed forever. Online gaming is exploding and gaining popularity every day. There are thousands and thousands of sites and apps offering new ways to experience games. Technology has brought all sorts of games, from augmented reality to even real money blackjack right to your home, to play, practise and excel.

Conservation

A vital topic on todays world, conservation efforts have benefitted from technology. From drone technology to monitor animals and birds, to embedded chips to keep track of movements and births, technology is helping dedicated people everywhere make the planet a better place. Ocean currents, rising temperatures, glacier cleavages, deforestation and afforestation- technology is helping us keep track of nature.

Entrepreneurship

There was a time when small and medium enterprises could not operate beyond local sales. Now, these sites have websites and more people are getting to know of them and their products and services. Companies have clients from all over the world, bringing valuable experience and expertise in its wake.

Social media

Social media has defined the decade for sure. From influencer behaviour, to finding new friends, social media presence has been ubiquitous. Instagram is a visual delight, Twitter is for clever repartee, and YouTube channels can teach you everything from how to cook to how to pitch a tent.

The editorial unit

Read the original:
How technology has changed the world in the last decade - The Upcoming

Stem Cell Market Analysis, Growth By Top Companies, Trends By Types And Application, Forecast Analysis To 2027 – Market Research Sheets

By Stell Cell Research

The study on the Global Stem Cell Market attempts to provide significant and detailed insights into the latest market scenario and the emerging growth prospects. The report on Stem Cell Market also emphasizes on market leading players as well as the new entrants in the market landscape. The expansive research will help the new top players as well as the well-established players to set up their business strategies and achieve their short-term and long-term goals and can make better decisions. The report also adds important details of the assessment of the scope of the geographies and where the key participants should move forward to find latest growth bussiness opportunities in the future.

Get the Inside Scoop and Research Methodology of this Sample Report

Scope of Stem Cell Market:

Primary and secondary data collection methods are used to collect the data from reliable sources across the globe that include key players, end users, suppliers, members of associations across the countries and end user industries.Advanced research techniques and tools are used to prepare the report that make this report accurate and up-to-date with latest industry trends.

The Report covers following things

Stem Cell Market: Segmentation

Segmental analysis is one of the key sections of this report. The authors of the report have segregated the Stem Cell market into product type, application, end user, and region. All the segments are studied on the basis of their CAGR, market share, and growth potential. In the regional analysis, the report highlights the regional markets having high growth potential. This clear and thorough assessment of the segments would help the players to focus on revenue generating areas of the Stem Cell market.

Highlight Of The Reports

Get Discount on this Report:https://www.worldwidemarketreports.com/check/discount/stem-cell-market-analysis,-growth-by-top-companies,-trends-by-types-and-application,-forecast-analysis-to-2027

Research objectives

To perceive the most influencing, pivoting and hindering forces in the Stem Cell Market and its footprint in the international market.

To gain a perceptive survey of the market and have an extensive interpretation of the Stem Cell Market and its materialistic landscape.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To project the consumption of Stem Cell submarkets, with respect to key regions (along with their respective key countries).

To strategically profile the top key players and comprehensively analyze their growth strategies.

Important Stem Cell Market Data Available In This Report:

Emerging Opportunities, Competitive Landscape, Revenue Share of Main Manufacturers.

This Report Discusses the Stem Cell Market Summary; Market Scope Gives A Brief Outline of the Stem Cell Market.

Key Performing Regions (APAC, EMEA, Americas, Other) Along With Their Major Countries Are Detailed in This Stem Cell industry Report.

Company Profiles, Product Analysis, Marketing Strategies, Emerging Market Segments and Comprehensive Analysis of Stem Cell Market.

Stem Cell Market Share Year-Over-Year Growth of Key Players In Promising Regions.

Read more:
Stem Cell Market Analysis, Growth By Top Companies, Trends By Types And Application, Forecast Analysis To 2027 - Market Research Sheets

The most important health innovations of the past decade – The Hill

By Stem Cell Clinic

The 2010s are coming to an end, and looking back there have been some pretty amazing advances and innovations in health and science.

Advances in prosthetic limbs

Prosthetic limbs have been around since ancient times. In Egypt, a prosthetic wooden toe was found on a mummy dating back 3,000 years. By the Dark Ages, inventors could incorporate hinges on prosthetic arms used by knights. In modern times, the field of prosthetics has turned to incorporating more technology into physical stand-ins for limbs. In the last several years, theres been a boom in advances that have led to the best and most useful prosthetics weve ever seen.

Reports from the early 2010s talked about the potential for new technology to allow people to control prosthetics with their minds and to receive sensory information from their devices. It may have been a reach in the early part of the decade, but now it is literally within grasp. There are new prosthetic hands being tested that give the user the ability to grab objects with their thoughts and even to sense the texture of what they are touching. New bionic hands allow the user to feel again by sending signals back to the brain about the things they are touching, like whether its hard or soft. Other research groups have been working on bionic arms that can move based on the users thoughts through a brain-computer interface. While these have demonstrated its possible to accomplish these goals in the lab, theres still more to be done before people can use these devices outside in the real world.

Many of these advanced prosthetics are still prototypes and may not reach the general population for a while. Luckily, cheaper 3D printers have made simple prosthetics more accessible. These are important because a prosthetic device can improve the quality of life for people. For example, this person has been printing prosthetic hands and arms for people in Africa after watching an online tutorial. New materials that go into 3D printers are cheaper than they used to be and are being used in prosthetics to provide a more affordable option for patients.

Although prosthetics have been around for ages in some form or another, they arent always used. One variable to consider is the social acceptance of having a prosthetic. Theres still a lot of stigma around disabilities and many people may reject prosthetics even if they are available. In 2012, an athlete with both feet amputated competed in the mens 400 meter race at the Olympics in London. There was some controversy over whether the runner with a prosthetic foot should be allowed to run in races with people who dont have prosthetics or if they should only be allowed in competitions specifically for people who have them. Prosthetics also need to be comfortable and usable in order to be successfully adopted. In one study, about 4.5 percent of people rejected prosthetics and 13.4 percent stopped using their prosthetics. As the new prosthetics that are more natural and intuitive to use come to market, hopefully more people will benefit, and the social barriers to acceptance will disappear.

CRISPR

The genome modification technique called Clustered Regularly Interspaced Short Palindromic Repeats, aka CRISPR, was a culmination of a few decades of work by scientists, and major studies explaining the method were published in 2013. The version of it called CRISPR-associated protein 9 or CRIPSR-Cas9 is what most researchers are specifically using in most cases. It involves a regular gene editing mechanism that happens in bacteria. The bacteria can take sections of DNA from attacking viruses and essentially use that to remember the viruses if they return. When the virus is back, the bacteria can target the matching sections of DNA in the virus, cut it and disable the virus.

Though 2013 was only six years ago, as far as science goes, CRISPR has been moving at lightning speed towards practical applications. Using CRISPR to edit a gene sequence, researchers can now add, delete or modify DNA segments more quickly and accurately than ever before. Since the technique was developed, researchers have used CRISPR to target diseases caused by a single gene like cystic fibrosis or sickle cell disease.

Probably the most infamous use of CRISPR are the CRISPR babies. In late 2018, a Chinese researcher, He Jiankui, claimed to have used CRISPR to modify the genomes of two babies to include a mutated version of a gene that protects against HIV. This case was and is highly controversial for the ethical concerns with genetically modifying a human genome at the embryo level, or germline, meaning it can be passed down to future generations and has not been done before in humans. Recently, MIT Technology Review obtained excerpts from Hes research, and experts say that the report and data may be untrustworthy. This means it is still unclear if He and collaborators actually successfully modified the babies genomes. The scientific community overall condemns this way of using CRISPR to edit a human germline genome and has called for an international moratorium on it until a framework can be agreed on.The researcher has been sentenced to three years in prison in Shenzhen, China.

As fraught with controversy as the CRISPR babies may be, CRISPR technology still holds a lot of promise and can be used responsibly, supporters say. For example, researchers are using it to target cancer cells by taking a patients immune cells, modifying them using CRISPR and then infusing the patient with the modified cells. For blood diseases, a patient with sickle cell disease is reported to be responding well to a CRISPR treatment that has allowed her body to produce a crucial protein.

Another area that has boomed this decade partly because of CRISPR technology is stem cell therapy, which well get into in the next section.

Stem cell therapy

Technically, the only Federal Drug Administration (FDA)-approved stem cell therapies are blood-forming stem cells derived from umbilical cord blood. Blood-forming stem cells are used to treat patients with cancer after chemotherapy has depleted blood cells, as well as patients with blood disorders like leukemia whose bone marrow tissues are damaged. These types of treatments have been around for about 30 years, but in the 2010s weve seen potential for more uses of stem cells in health care.

The main idea behind stem cell therapy is that because the cells are pluripotent meaning they can become many other types of cells they can be introduced into parts of the body that are damaged and need new cells. On top of that, researchers can now extract some types of stem cells from a persons body, so no need for umbilical cords. This opens up the possibilities for highly personalized treatment where one person can be treated with stem cells from their own body.

Researchers are exploring how stem cells can be used to treat liver disease, cerebral palsy, stroke, brain injury and others. There are many ongoing research-backed clinical trials for stem cell therapy. A quick search for stem cell therapy on the governments clinical trial database turns up 5,638 results. And because of the work necessary to even get to the clinical trial stage, theres likely an order of magnitude more stem cell therapy studies in the pre-clinical trial stages.

Stem cell therapy is also being offered in for-profit clinics around the U.S. In these cases, the clinics are typically taking fat tissue from a patient, isolating the stem cells and then administering the stem cells back to the patient. In some cases, the treatments may lead to health complications, like blindness in a few extreme cases, and the FDA warns that such treatments are unapproved and potentially harmful. The FDA is ramping up regulation of stem cell clinics and earlier this year took a specific clinic in Florida to court.

Although there are many stem cell clinics offering unproven stem cell therapies, its not all hype. Granted that its difficult to pass the clinical trial stage to get FDA approval, stem cell research may lead to new treatments for several health conditions that could completely change the health care landscape.

You can follow Chia-Yi Hou on Twitter.

Here is the original post:
The most important health innovations of the past decade - The Hill

→←